Qiagen NV | QIA - Market Capitalization

Stock Price
35.26
Daily Change
-0.34 -0.96%
Monthly
-13.98%
Yearly
-2.97%
Q1 Forecast
35.13

Qiagen NV reported $7.76B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 312M 115M Mar/2026
Alaunos Therapeutics USD 50M 45M Mar/2026
argenx SE USD 35.7B 16.14B Mar/2026
Avita Medical AUD 164.6M 59.13M Mar/2026
Dianthus Therapeutics USD 2.32B 535M Mar/2026
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
IQVIA Holdings USD 38.39B 6.1B Dec/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Qiagen NV USD 7.87B 2.03B Mar/2026
Revvity USD 10.97B 1.21B Dec/2025
Tectonic Therapeutic USD 474M 84M Mar/2026
Viatris USD 14.34B 2.8B Dec/2025
Xeris Pharmaceuticals USD 788M 515M Mar/2026